The Influence of BCG Vaccine as a Booster TDaP-IPV Vaccination: an Explorative Study

Trial Profile

The Influence of BCG Vaccine as a Booster TDaP-IPV Vaccination: an Explorative Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs BCG vaccine (Primary) ; DTaP poliovirus vaccine (Primary)
  • Indications Pertussis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Oct 2016 Planned End Date changed from 1 Feb 2017 to 1 Apr 2017.
    • 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 17 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top